Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections.

Wyeth

Status: Completed

Conditions: Urinary Infections

Treatments: Drug: piperacillin/tazobactam

Study type: Observational

Funder types: Industry

Identifiers

NCT00195286

101315

Details and patient eligibility

About

The primary objective is to study the efficacy of piperacillin/tazobactam in patients with complicated urinary tract infections

Enrollment: 180 patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hospitalized patients over 16 years of age with complicated urinary infection produced by bacteria that are suspected to be susceptible to treatment with Piperacillin-tazobactam.

Exclusion criteria

• Patients known, or thought to be hypersensitivity to beta-lactams
• Patients with an uncomplicated urinary tract infection